Nordea Investment Management
SRPT icon

Nordea Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Nordea Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Hold
38,451
– – ﹤0.01% 889
2026
Q1 		$822K Sell
38,451
-24,866
-39% -$481K ﹤0.01% 841
2025
Q4 		$1.36M Sell
63,317
-8,534
-12% -$180K ﹤0.01% 808
2025
Q3 		$1.31M Buy
71,851
+2,488
+4% +$44.4K ﹤0.01% 794
2025
Q2 		$1.18M Buy
69,363
+1,066
+2% +$45.5K ﹤0.01% 806
2025
Q1 		$4.38M Buy
68,297
+751
+1% +$79.1K ﹤0.01% 559
2024
Q4 		$8.23M Buy
67,546
+10,815
+19% +$1.33M 0.01% 448
2024
Q3 		$7.11M Sell
56,731
-2,670
-4% -$369K 0.01% 471
2024
Q2 		$9.33M Sell
59,401
-2,256
-4% -$290K 0.01% 412
2024
Q1 		$8M Buy
61,657
+33,711
+121% +$4.13M 0.01% 456
2023
Q4 		$2.72M Sell
27,946
-350
-1% -$33.6K ﹤0.01% 659
2023
Q3 		$3.48M Buy
28,296
+12
+0% +$1.36K ﹤0.01% 583
2023
Q2 		$3.2M Buy
28,284
+16,774
+146% +$2.16M ﹤0.01% 609
2023
Q1 		$1.58M Buy
+11,510
New +$1.49M ﹤0.01% 714
2021
Q2 		– Sell
-3,193
Closed -$234K – 1004
2021
Q1 		$234K Hold
3,193
– – ﹤0.01% 961
2020
Q4 		$544K Hold
3,193
– – ﹤0.01% 848
2020
Q3 		$458K Sell
3,193
-3,193
-50% -$485K ﹤0.01% 831
2020
Q2 		$1.02M Buy
6,386
+3,193
+100% +$435K ﹤0.01% 793
2020
Q1 		$313K Hold
3,193
– – ﹤0.01% 864
2019
Q4 		$415K Sell
3,193
-2,146
-40% -$217K ﹤0.01% 874
2019
Q3 		$400K Buy
+5,339
New +$631K ﹤0.01% 882

Other funds holding SRPT

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Nordea Investment Management's SRPT Position: Q2 2026 in Review

Nordea Investment Management held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 38,451 shares worth $681K. The position accounts for ﹤0.01% of the portfolio, ranked #889.

Nordea Investment Management first reported a position in SRPT in Q3 2019 and has held it in 21 quarters since. The position peaked at $9.33M in Q2 2024. 100 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Nordea Investment Management held 38,451 shares of Sarepta Therapeutics worth $681K as of Q2 2026.
  • Nordea Investment Management left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #889 holding.
  • Nordea Investment Management first reported a position in Sarepta Therapeutics in Q3 2019 and has held it in 21 quarters since.
  • Nordea Investment Management's Sarepta Therapeutics position peaked at $9.33M in Q2 2024.
  • 100 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.